Randomized, Masked, Placebo-Controlled, Multicenter, Phase 3 Study of Batoclimab for Active, Moderate-To-Severe Thyroid Eye Disease (ATA 2026) - Sep 19, 2026 - Abstract #P543; Pres time: Nov 6, 2026; 10:00 AM - 11:00 AM; No abstract available
Clinical • P3 data • Ophthalmology • Thyroid Eye Disease
|
|
George Kahaly; Antonio Manuel Garrido-Hermosilla; Annick Van Den Bruel; Daniel Briscoe; Michele Marino; Takahiro Hiraoka; Jonathan Janes; E Lin; Marius Stan
|